These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15561275)

  • 1. Syenergistic effect of 15-deoxyspergualin with costimulation blockade on alloimmune response.
    Shirasugi N; Aramaki O; Hatano M; Suda H; Tanaka K; Inoue F; Akiyoshi T; Shimazu M; Kitajima M; Niimi M
    Transplant Proc; 2004 Oct; 36(8):2446-7. PubMed ID: 15561275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 and IL-4 in skin allograft survival induced by T-cell depletion plus deoxyspergualin.
    Asiedu C; Andrades P; Ray PD; George JF; Thomas JM
    Cell Transplant; 2008; 17(6):713-20. PubMed ID: 18819259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
    Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
    Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model.
    Alegre ML; Sattar HA; Herold KC; Smith J; Tepper MA; Bluestone JA
    Transplantation; 1994 Jun; 57(12):1786-94. PubMed ID: 8016885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
    Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
    Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1996 May; 17(5):789-92. PubMed ID: 8733699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.
    Valdivia LA; Monden M; Gotoh M; Nakano Y; Tono T; Mori T
    Transplantation; 1990 Jul; 50(1):132-6. PubMed ID: 2368132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.
    Metzler B; Gfeller P; Wieczorek G; Katopodis A
    Transpl Immunol; 2008 Nov; 20(1-2):106-12. PubMed ID: 18675355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of donor-specific blood transfusion and a short course of deoxyspergualin in rat kidney transplantation.
    Tanabe K; Yasuo M; Nemoto K; Takahashi K; Toma H; Ota K
    Transpl Int; 1996; 9(4):353-8. PubMed ID: 8819269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of deoxyspergualin (DSG) on rejection and graft-versus-host disease (GVHD) after small bowel transplantation.
    Makabe M; Tanaka S; Orita K
    Transpl Int; 1994; 7 Suppl 1():S449-52. PubMed ID: 11271278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
    Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.